Halozyme Therapeutics Inc (HALO)
45.73
-0.03
(-0.07%)
USD |
NASDAQ |
Nov 21, 16:00
45.82
+0.09
(+0.20%)
After-Hours: 20:00
Halozyme Therapeutics Profit Margin (Quarterly): 47.23% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 47.23% |
| June 30, 2024 | 40.30% |
| March 31, 2024 | 39.22% |
| December 31, 2023 | 37.12% |
| September 30, 2023 | 37.88% |
| June 30, 2023 | 33.82% |
| March 31, 2023 | 24.43% |
| December 31, 2022 | 31.79% |
| September 30, 2022 | 29.49% |
| June 30, 2022 | 14.89% |
| March 31, 2022 | 51.25% |
| December 31, 2021 | 65.46% |
| September 30, 2021 | |
| June 30, 2021 | 67.02% |
| March 31, 2021 | 31.34% |
| December 31, 2020 | 60.12% |
| September 30, 2020 | 55.43% |
| June 30, 2020 | 46.75% |
| March 31, 2020 | -24.07% |
| December 31, 2019 | -64.10% |
| September 30, 2019 | -54.11% |
| June 30, 2019 | -37.36% |
| March 31, 2019 | 3.15% |
| December 31, 2018 | -3.53% |
| September 30, 2018 | -109.0% |
| Date | Value |
|---|---|
| June 30, 2018 | -65.03% |
| March 31, 2018 | -88.95% |
| December 31, 2017 | 65.35% |
| September 30, 2017 | 4.31% |
| June 30, 2017 | -91.15% |
| March 31, 2017 | -111.3% |
| December 31, 2016 | -70.22% |
| September 30, 2016 | -90.87% |
| June 30, 2016 | -80.62% |
| March 31, 2016 | -46.63% |
| December 31, 2015 | 8.27% |
| September 30, 2015 | -117.7% |
| June 30, 2015 | 6.96% |
| March 31, 2015 | -80.94% |
| December 31, 2014 | -17.36% |
| September 30, 2014 | -138.8% |
| June 30, 2014 | -88.51% |
| March 31, 2014 | -221.9% |
| December 31, 2013 | -175.9% |
| September 30, 2013 | -120.5% |
| June 30, 2013 | -158.5% |
| March 31, 2013 | -163.0% |
| December 31, 2012 | -20.22% |
| September 30, 2012 | -375.0% |
| June 30, 2012 | -180.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-64.10%
Minimum
Dec 2019
67.02%
Maximum
Jun 2021
32.92%
Average
37.88%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 15.48% |
| Novavax Inc | -143.5% |
| Insulet Corp | 14.25% |
| BioLife Solutions Inc | -5.57% |
| TransMedics Group Inc | 3.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 156.6% |
| Return on Assets | 20.54% |
| Return on Invested Capital | 22.41% |
| Gross Profit Margin (Quarterly) | 82.96% |
| Operating Margin (Quarterly) | 56.26% |
| Return on Net Operating Assets | 29.73% |